Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: Novel potassium channel openers

被引:26
作者
Cho, H
Katoh, S
Sayama, S
Murakami, K
Nakanishi, H
Kajimoto, Y
Ueno, H
Kawasaki, H
Aisaka, K
Uchida, I
机构
[1] Japan Tobacco Inc., Ctrl. Pharmaceutical Res. Institute, Takatsuki, Osaka 569, 1-1, Murasaki-cho
关键词
D O I
10.1021/jm960270l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A variety of compounds having a benzopyran such as levcromakalim generally exhibit potent antihypertensive activity. During extensive investigations aimed toward identifying K+ channel openers having selective coronary vasodilation without potent hypotensive and tachycardiac effects, we synthesized a series of 3,4-dihydro-2H-1-benzopyran-3-ol derivatives modified at positions 2, 4, and 6 in the benzopyran ring. Initially, compounds having two methoxymethyl groups at position 2 were found to show a selective effect on coronary blood flow (CoBF) relative to mean arterial pressure (MAP) in anesthetized dogs. To find more potent vasodilators, various benzopyran derivatives modified at position 4 were synthesized and structure-activity relationships were examined by evaluation of the extent and duration of the increase in CoBF in anesthetized dogs. As a result, compounds having a (1,6-dihydro-6-oxopyridazin-3-yl)amino group at position 4, in addition to the two methoxymethyl groups at position 2, were found to be more potent and to have an improved duration of action. Among these compounds, JTV-506, (-)-(3S,4R)-6-cyano-3,4-dihydro-4-[(1,6-dihydro-1-methyl-6-oxopyridazin-3-yl)amino]-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol, exhibited good selectivity for its effect. Administration of this compound (0.03 mg/kg, po) elicited an increase of CoBF without a change of systemic blood pressure and heart rate (HR) in conscious dogs. Further evaluation was performed with respect to (i) the selectivity of its action on the coronary artery versus the aorta and (ii) its effects on MAP, HR, and electrocardiographic ST elevation. As a result, JTV-506 was selected as a potent and selective coronary vasodilator with various pharmacological features favoring clinical development.
引用
收藏
页码:3797 / 3805
页数:9
相关论文
共 19 条
[1]   CARDIOSELECTIVE ANTIISCHEMIC ATP-SENSITIVE POTASSIUM CHANNEL OPENERS .2. STRUCTURE-ACTIVITY STUDIES ON BENZOPYRANYLCYANOGUANIDINES - MODIFICATION OF THE BENZOPYRAN RING [J].
ATWAL, KS ;
GROVER, GJ ;
FERRARA, FN ;
AHMED, SZ ;
SLEPH, PG ;
DZWONCZYK, S ;
NORMANDIN, DE .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (11) :1966-1973
[2]  
BAUMGARTH M, Patent No. 4300880
[3]   SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY OF 4-(1,2-DIHYDRO-2-OXO-1-PYRIDYL)-2H-1-BENZOPYRANS AND RELATED-COMPOUNDS, NEW POTASSIUM CHANNEL ACTIVATORS [J].
BERGMANN, R ;
GERICKE, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (02) :492-504
[4]  
CHO H, Patent No. 9513272
[5]   BENZOPYRONES .8. MONO-TETRAZOL-5-YLCHROMONES AND DI-TETRAZOL-5-YLCHROMONES - INFRARED CYANO-ABSORPTION OF SOME 4-OXOCHROMENCARBONITRILES [J].
ELLIS, GP ;
SHAW, D .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1972, (06) :779-&
[6]   3-METHYL-2H-1-BENZOPYRAN POTASSIUM CHANNEL ACTIVATORS [J].
GERICKE, R ;
HARTING, J ;
LUES, I ;
SCHITTENHELM, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (10) :3074-3085
[7]  
HORIE T, 1962, Chem Pharm Bull (Tokyo), V10, P580
[8]  
IZAWA T, Patent No. 388528
[9]  
KATOH S, Patent No. 9502589
[10]  
KATOH S, 1991, Patent No. 91188374